FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 358:1089-1092 March 13, 2008 Number 11 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Slide Presentation Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear

Africa is facing the worst tuberculosis epidemic since the advent of the antibiotic era. Driven by a generalized human immunodeficiency virus (HIV) epidemic and compounded by weak health care systems, inadequate laboratories, and conditions that promote transmission of infection, this devastating situation has steadily worsened, exacerbated by the emergence of drug-resistant strains of tuberculosis.

Africa, home to 11% of the world's population, carries 29% of the global burden of tuberculosis cases and 34% of related deaths, and the challenges of controlling the disease in the region have never been greater. The World Health Organization (WHO) estimates that the average incidence . . . [Full Text of this Article]

Source Information

Dr. Chaisson is the director of the Center for Tuberculosis Research at the Johns Hopkins University School of Medicine, Baltimore. Dr. Martinson is the deputy director of the Perinatal HIV Research Unit, University of the Witwatersrand, Soweto, South Africa.

A slide presentation on tuberculosis and HIV in Africa may be seen at www.nejm.org.

This article has been cited by other articles:

• Mohamed, A. M., Abou El-Ella, G. A., Nasr, E. A. (2009). Phenotypic and molecular typing of tuberculous and nontuberculous Mycobacterium species from slaughtered pigs in Egypt. jvdi 21: 48-52 [Abstract] [Full Text]  
• Khawcharoenporn, T, Apisarnthanarak, A, Mundy, L M (2008). Assessment of risk for pulmonary tuberculosis after non-reactive tuberculin skin testing among patients with HIV infection in a resource-limited setting. Int J STD AIDS 19: 843-847 [Abstract] [Full Text]  
• Kim, D. H., Kim, H. J., Park, S.-K., Kong, S.-J., Kim, Y. S., Kim, T.-H., Kim, E. K., Lee, K. M., Lee, S. S., Park, J. S., Koh, W.-J., Lee, C.-H., Kim, J. Y., Shim, T. S. (2008). Treatment Outcomes and Long-term Survival in Patients with Extensively Drug-resistant Tuberculosis. Am. J. Respir. Crit. Care Med. 178: 1075-1082 [Abstract] [Full Text]  
• Rosenthal, I. M., Zhang, M., Almeida, D., Grosset, J. H., Nuermberger, E. L. (2008). Isoniazid or Moxifloxacin in Rifapentine-based Regimens for Experimental Tuberculosis?. Am. J. Respir. Crit. Care Med. 178: 989-993 [Abstract] [Full Text]